Table 3.
Incidence of adverse events during treatment.
| Adverse event | HIFU alone (n = 30) | CEUS+HIFU (n = 34) | P |
| Sacrococcygeal pain | 5/30 (16.7%) | 4/34 (11.8%) | .573 |
| Skin burn | 0/30 (0%) | 0/34 (0%) | – |
| Pain in treatment zone | 6/30 (20.0%) | 8/34 (23.5%) | .733 |
| Groin pain | 1/30 (3.3%) | 0/34 (0%) | .469 |
| Sensation of rectal tenesmus | 2/30 (6.7%) | 1/34 (2.9%) | .482 |
| Leg pain | 1/30 (3.3%) | 0/34 (0%) | .469 |
Data are presented as n/N (%). The following pain rating scale was used: 0 = painless; 1 to 2 = mild pain; 3 to 4 = moderate pain; 5 to 6 = severe pain; 7 to 8 = very severe pain; and 9 to 10 = unbearable pain. The pain score was <4 points in all patients.